| Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963) |
|---|
| 06/23/2005 | US20050137395 E.g., 6-[(7-iodoquinolin-4-yl)oxy]-N,2-dimethyl-1-benzofuran-3-carboxamide; antiproliferative agent for hyperproliferative disorders being either cancerous or noncancerous; vasculogenesis or angiogenesis inhibitors; adminstered with hypotensive agent, antitumor agents, mitotic inhibitors and others |
| 06/23/2005 | US20050137234 Histone deacetylase inhibitors |
| 06/23/2005 | US20050137228 Benzyl sulfonamide derivatives |
| 06/23/2005 | US20050137190 Compositions useful as inhibitors of voltage-gated sodium channels |
| 06/22/2005 | EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 06/22/2005 | EP1542675A1 Compounds useful for the inhibition of aldh |
| 06/22/2005 | EP1263749B1 Taxane anticancer agents |
| 06/22/2005 | CN1630642A Benzenesulfonamide derivatives |
| 06/22/2005 | CN1629283A Epothilone -a microtubule stabilizer for treating tumor and blood vessel restenosis |
| 06/21/2005 | US6908942 Carbocyclic oxy amines such as 2,2-dimethyl-3-(4-fluorobenzyl) ether-4-methoxy-6-(4-methoxybenzyl)amino Benzopyran and libraries, used for prophylaxis of eating disorders induced by lipid peroxidation; antioxidants |
| 06/16/2005 | WO2005054809A2 Irciniastatins a and b |
| 06/16/2005 | WO2005054221A1 Gsk-3 inhibitors isolated from marine organisms |
| 06/16/2005 | WO2005054210A1 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 06/16/2005 | WO2005054201A1 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 06/16/2005 | WO2005054179A2 Hydroxamic acid esters and pharmaceutical use thereof |
| 06/16/2005 | WO2005040116A3 Indolinone derivatives and their use in treating disease-states such as cancer |
| 06/16/2005 | US20050130959 Selective in presence of at least one other cathepsin isozyme; such as (3-cyclopentyl-{[5-(3-fluoro-phenyl)-furan-2-carbonyl]-amino}-propionylamino)-4-oxo-butyric acid |
| 06/16/2005 | US20050130221 Synthesis for the preparation of compounds for screening as potential tubulin binding agents |
| 06/16/2005 | CA2549242A1 Hydroxamic acid esters and pharmaceutical use thereof |
| 06/16/2005 | CA2546657A1 6-substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 06/15/2005 | EP1541570A1 Novel physiologically active substance |
| 06/15/2005 | EP1541551A1 2-cyano-4-fluoropyrrolidine derivative or its salt |
| 06/15/2005 | EP1539693A1 Cannabinoid receptor agonists |
| 06/15/2005 | EP1248785B1 Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 06/14/2005 | US6906203 Anticancer agents; such as 2-Amino-3-cyano-4-(2-bromo-4,5-dimethoxyphenyl)-4H-indolo(4,5-b)pyran |
| 06/14/2005 | US6906088 Taxanes having a carbamoyloxy substituent at C(10), a hydroxy substituent at C(7), and a range of C(2), C(9), C(14), and side chain substitutions; anticarcinogenic agent |
| 06/14/2005 | CA2304967C 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 06/09/2005 | WO2005051938A1 Vitamin d receptor modulators |
| 06/09/2005 | WO2005051890A1 Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to gpr40 |
| 06/09/2005 | US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy |
| 06/09/2005 | US20050124671 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 06/09/2005 | US20050124654 Compounds and methods of use |
| 06/09/2005 | US20050123831 used for ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions |
| 06/09/2005 | CA2546614A1 Dna participating in hydroxylation of macrolide compound |
| 06/09/2005 | CA2544857A1 Vitamin d receptor modulators |
| 06/08/2005 | EP1537084A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of |
| 06/08/2005 | EP1268306A4 Inverted aerosol dispenser |
| 06/08/2005 | EP1112263B1 Polymerizable polyalkoxylated naphthopyrans |
| 06/08/2005 | EP1089735B1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists |
| 06/08/2005 | CN1625408A Improved kavalactone profile |
| 06/08/2005 | CN1625394A Processes for preparing crystalline and amorphous mupirocin calcium |
| 06/08/2005 | CN1623537A Biaryl sulfonamides and its using method |
| 06/08/2005 | CN1205198C Cyclic ketone derivative and pharmaceutical use thereof |
| 06/08/2005 | CN1205184C Beta-lactan |
| 06/07/2005 | US6903133 Anticancer compounds |
| 06/07/2005 | US6903095 Phthalimido derivatives and a process for their preparation |
| 06/02/2005 | WO2005016878A3 METHODS FOR THE PREPARATION OF 5-FLUORO-PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS |
| 06/02/2005 | CA2556801A1 Methods and agents for inhibiting dynamin-dependent endocytosis |
| 06/01/2005 | EP1535909A2 Cyclic amine derivatives and their use as drugs |
| 06/01/2005 | EP1534689A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof |
| 06/01/2005 | EP1534674A2 Cytotoxic agents containing novel potent taxanes and their therapeutic use |
| 06/01/2005 | EP1534277A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 06/01/2005 | EP1248761A4 Compounds which mimic the chemical and biological properties of discodermolide |
| 05/31/2005 | US6900340 Alcoholysis of ketene, forming ester; then hydrolysis |
| 05/31/2005 | US6900227 Benzodioxole derivatives |
| 05/31/2005 | CA2158275C Taxanes having an amino substituted side-chain |
| 05/26/2005 | US20050113383 For therapy of allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep |
| 05/26/2005 | US20050113374 Benzodioxepine derivatives |
| 05/26/2005 | US20050113357 Cholinergic agents such as 3-[3-(4-methoxypiperidine)-1-yl-propyl]-1H-indole; for therapy of cognitive dysfunction, forgetfulness, confusion, memory loss, attention deficits, deficits in visual perception, depression, pain, sleep disorders, and psychosis |
| 05/25/2005 | EP1532139A1 Total synthesis of myriaporones |
| 05/25/2005 | EP1532132A1 Novel benzodioxoles |
| 05/25/2005 | CN1620447A Isochroman compounds for treatment of cns disorders |
| 05/25/2005 | CN1620435A 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 05/25/2005 | CN1203184C Process for preparation of pseudomonic acid A antibiotic by microbiological method |
| 05/25/2005 | CN1203066C (Methylsulfonyl) phenyl-2-(5H)-furanones as cos-2 inhibitors |
| 05/19/2005 | WO2005044817A1 Modulators of cellular adhesion |
| 05/19/2005 | WO2005044814A1 BENZO [b][1,4] DIOXEPINE DERIVATIVES |
| 05/19/2005 | US20050107428 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders |
| 05/19/2005 | DE10348298A1 Amidomethyl-substituierte 2-(4-Sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-ylderivade, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel Amidomethyl-substituted 2- (4-sulphonylamino) -3-hydroxy-3,4-dihydro-2H-chromen-6-ylderivade, processes and intermediates for their preparation containing these compounds and pharmaceutical |
| 05/19/2005 | CA2551056A1 Benzo[b][1,4]dioxepine derivatives |
| 05/19/2005 | CA2544678A1 Modulators of cellular adhesion |
| 05/17/2005 | US6894177 Viricides; human immunodeficiency virus |
| 05/12/2005 | WO2005042539A1 Tocopherol-modified therapeutic drug compounds |
| 05/12/2005 | WO2005042521A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 05/12/2005 | WO2005014537A3 Tetrahydropyran heterocyclic cyclopentyl heteroaryl modulators of chemokine receptor activity |
| 05/12/2005 | WO2005007635A8 Combretastatin derivatives with cytotoxic action |
| 05/12/2005 | US20050101781 Eponemycin and epoxomicin analogs and uses thereof |
| 05/12/2005 | US20050101641 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/12/2005 | CA2543715A1 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 05/11/2005 | EP1529053A2 Macrolide compounds endowed with antiinflammatory activity |
| 05/11/2005 | EP1528924A1 Mch1r antagonists |
| 05/11/2005 | CN1615132A Melanogenesis inhibitors and whitening agents comprising egonol derivatives and compositions containing egonol derivatives |
| 05/11/2005 | CN1200939C Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 05/10/2005 | US6890937 Inhibiting the activity of one or more of MMP-2, MMP-9 and MMP-13, while exhibiting substantially less inhibitory activity against MMP-1 |
| 05/10/2005 | US6890928 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/10/2005 | CA2222995C Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides |
| 05/06/2005 | WO2005040116A2 Indolinone derivatives and their use in treating disease-states such as cancer |
| 05/06/2005 | WO2005039496A2 Inhibitors of cathepsin s |
| 05/06/2005 | WO2004092116A8 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 05/06/2005 | CA2542963A1 Inhibitors of cathepsin s |
| 05/06/2005 | CA2541460A1 Indolinone derivatives and their use in treating disease-states such as cancer |
| 05/05/2005 | US20050096340 lipophilic derivatives of paclitaxel, camptothecin, docetaxel or derivatives thereof; tocopherol succinate paclitaxel for example; emulsions for drug delivery, treating cancer; increased plasma elimination half-life compared to the parent therapeutic drug |
| 05/04/2005 | EP1446399B1 Piperazine derivatives having sst1 antagonistic activity |
| 05/04/2005 | EP1317448B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2005 | EP0792468B2 Novel photochromic indeno-fused naphthopyrans |
| 05/04/2005 | CN1611495A Compound having an epoxy group and a chalcone group, method of preparing the same, and photoresist composition comprising the same |
| 05/04/2005 | CN1199970C Di-pentaheterocycle substituted fulgide photochromic compounds and its synthetic method and use |
| 05/03/2005 | US6887877 Viricide for hepatitis virus |
| 04/28/2005 | WO2005037780A2 Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromium-6-yl-derivatives and drugs containing said compounds |
| 04/28/2005 | WO2005037272A1 Benzimidazole derivatives and use thereof as peptide deformylase inhibitors |